Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 8
2004 3
2005 8
2006 9
2007 13
2008 9
2009 7
2010 7
2011 11
2012 17
2013 24
2014 25
2015 22
2016 20
2017 19
2018 28
2019 29
2020 29
2021 20
2022 19
2023 19
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

320 results

Results by year

Filters applied: . Clear all
Page 1
High N6-methyladenosine-activated TCEAL8 mRNA is a novel pancreatic cancer marker.
Hara T, Meng S, Sato H, Tatekawa S, Sasaki K, Takeda Y, Tsuji Y, Arao Y, Ofusa K, Kitagawa T, Yamada D, Takahashi H, Kobayashi S, Motooka D, Suzuki Y, Rennie S, Uchida S, Mori M, Ogawa K, Doki Y, Eguchi H, Ishii H. Hara T, et al. Among authors: ogawa k. Cancer Sci. 2024 Apr 24. doi: 10.1111/cas.16152. Online ahead of print. Cancer Sci. 2024. PMID: 38659235
Reirradiation for recurrent gynecologic cancer using high-dose-rate brachytherapy in Japan: A multicenter survey on practice patterns and outcomes.
Isohashi F, Yoshida K, Murakami N, Masui K, Ishihara S, Ohkubo Y, Kaneyasu Y, Kinoshita R, Kotsuma T, Takaoka Y, Tanaka E, Nagao A, Ogawa K, Yamazaki H. Isohashi F, et al. Among authors: ogawa k. Radiother Oncol. 2024 Apr 5;195:110269. doi: 10.1016/j.radonc.2024.110269. Online ahead of print. Radiother Oncol. 2024. PMID: 38583719
Circulating Plasma Exosomal PD-L1 Predicts Prognosis of Head and Neck Squamous Cell Carcinoma After Radiation Therapy.
Tamari K, Minami K, Tatekawa S, Seo Y, Fukusumi T, Tanaka H, Suzuki M, Eguchi H, Takenaka Y, Hirata T, Hayashi K, Isohashi F, Shimizu S, Koizumi M, Inohara H, Ogawa K. Tamari K, et al. Among authors: ogawa k. Adv Radiat Oncol. 2023 Aug 15;9(2):101353. doi: 10.1016/j.adro.2023.101353. eCollection 2024 Feb. Adv Radiat Oncol. 2023. PMID: 38405303 Free PMC article.
RNA methylation in inflammatory bowel disease.
Ozato Y, Hara T, Meng S, Sato H, Tatekawa S, Uemura M, Yabumoto T, Uchida S, Ogawa K, Doki Y, Eguchi H, Ishii H. Ozato Y, et al. Among authors: ogawa k. Cancer Sci. 2024 Mar;115(3):723-733. doi: 10.1111/cas.16048. Epub 2024 Jan 23. Cancer Sci. 2024. PMID: 38263895 Free PMC article. Review.
A JROD survey: nationwide overview of radiotherapy data from 2015 to 2021.
Ohba H, Nakada Y, Numasaki H, Umehara K, Ota J, Okuda Y, Teshima T, Ogawa K, Nakamura K, Japanese Society For Radiation Oncology Database Committee. Ohba H, et al. Among authors: ogawa k. J Radiat Res. 2023 Nov 21;64(6):904-910. doi: 10.1093/jrr/rrad067. J Radiat Res. 2023. PMID: 37738418 Free PMC article.
320 results